Abiopharma

🔍 Colgrove John (Director)

Company: Everpure, Inc. (P)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Sold 77,579 shares of Class A Common Stock at $75.12 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 524,380.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 27,578 shares of Class A Common Stock at $75.01 per share (Direct)
  Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 496,802.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 29,108 shares of Class A Common Stock at $75.31 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 467,694.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-05 | Code: H | shares_owned_after: 6,725,221.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 2,715,000.00 | Footnotes: F6
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 2,715,000.00 | Footnotes: F7

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on behalf of Colgrove Family Living Trust on January 8, 2026.
• F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.40 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: Shares are held by Colgrove Family Living Trust.
• F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.69 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F6: Shares are held by The EEC Irrevocable Trust. A member of the Reporting Person's immediate family is a beneficiary of the trust.
• F7: Shares are held by The RWC Irrevocable Trust. A member of the Reporting Person's immediate family is a beneficiary of the trust.